Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use
Authors:
- Anthony J. SenagoreASAnthony J. Senagore
- Joel J. BauerJBJoel J. Bauer
- Wei DuWDWei Du
- Lee TechnerLTLee Techner
- 1 October 2007
- Vol. 142 (4) , 478-486
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Postoperative Ileus-Related Morbidity Profile in Patients Treated with Alvimopan after Bowel ResectionJournal of the American College of Surgeons, 2007
- Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trialsThe American Journal of Surgery, 2006
- Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgerySurgical Endoscopy, 2005
- Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal SurgeryDiseases of the Colon & Rectum, 2005
- Alvimopan, a Novel, Peripherally Acting μ Opioid AntagonistAnnals of Surgery, 2004
- Postoperative ileus: Etiologies and interventionsClinical Gastroenterology and Hepatology, 2003
- ‘Fast track’ postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgeryBritish Journal of Surgery, 2001
- Postoperative ileus: a preventable eventBritish Journal of Surgery, 2000
- Advanced age—indication or contraindication for laparoscopic colorectal surgery?Diseases of the Colon & Rectum, 1999
- Determinants of postoperative stay in patients with colorectal cancerDiseases of the Colon & Rectum, 1988